Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
CorrectionErratum

Correction to “Presynaptic Muscarinic M2-Receptor-Mediated Inhibition of N-Type Ca2+Channels in Cultured Sphenopalatine Ganglion: Direct Evidence for Acetylcholine Inhibition of Cerebral Nitrergic Neurogenic Vasodilation”

Journal of Pharmacology and Experimental Therapeutics September 2002, 302 (3) 1303;
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 302 no. 3 1303

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Published online September 1, 2002.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

Statistics from Altmetric.com

Article usage

Article usage: August 2002 to April 2023

AbstractFullPdf
Aug 200201820
Sep 20020107
Oct 2002072
Nov 2002031
Dec 2002090
Jan 2003052
Feb 2003025
Mar 2003070
Apr 2003006
May 2003011
Jun 2003020
Jul 2003060
Aug 2003040
Sep 2003051
Oct 2003053
Nov 2003040
Dec 2003010
Jan 2004090
Feb 2004053
Mar 2004040
Apr 2004020
May 2004060
Jun 2004061
Jul 20040112
Aug 2004080
Sep 2004043
Oct 2004041
Nov 2004061
Dec 2004030
Jan 20050101
Feb 2005040
Mar 2005041
Apr 2005010
May 2005020
Jun 2005030
Jul 2005021
Aug 2005010
Sep 2005010
Oct 2005021
Nov 2005030
Dec 2005010
Feb 2006050
Apr 2006001
May 2006020
Jun 2006030
Sep 2006001
Oct 2006001
Dec 2006010
Jan 2007010
Mar 2007010
Apr 2007021
Jun 2007010
Jul 2007021
Aug 2007010
Oct 2007002
Jan 2008001
Feb 2008010
Mar 2008020
Jun 2008020
Jul 2008002
Aug 2008010
Oct 2008031
Nov 2008051
Dec 2008020
Jan 2009011
May 2009010
Jun 2009001
Jul 2009010
Aug 2009002
Oct 2009010
Nov 2009010
Dec 2009010
Jan 2010020
Mar 2010010
Jul 2010001
Dec 2010010
Jan 2011010
Feb 2011031
Mar 2011051
Apr 2011062
May 2011031
Jun 2011046
Jul 2011096
Aug 2011079
Sep 2011093
Oct 2011055
Nov 2011080
Dec 2011041
Jan 2012011
Feb 2012052
Mar 20120100
Apr 2012053
May 20120121
Jun 2012040
Jul 20120100
Aug 2012051
Sep 2012050
Oct 2012091
Nov 20120111
Dec 2012044
Jan 2013051
Feb 2013011
Mar 2013041
Apr 20130130
May 2013062
Jul 2013030
Sep 2013062
Oct 2013020
Nov 2013021
Dec 2013020
Jan 2014020
Feb 2014050
Mar 2014080
Jun 2014010
Jul 2014020
Aug 2014060
Sep 2014030
Oct 2014020
Nov 2014040
Dec 2014050
Jan 2015021
Feb 2015010
Mar 2015060
Apr 2015040
Jun 2015010
Jul 2015014
Aug 2015010
Sep 2015010
Nov 2015010
Dec 2015030
Jan 2016040
Feb 2016062
Mar 2016010
Apr 2016020
Jun 2016010
Aug 2016010
Sep 2016020
Nov 2016001
Jan 2017010
Feb 2017030
Mar 2017010
Apr 2017040
May 2017010
Jun 2017050
Jul 2017030
Aug 2017040
Sep 2017050
Oct 2017010
Nov 2017020
Dec 2017010
Jan 2018060
Feb 2018022
Mar 2018030
Apr 2018051
May 2018081
Jun 2018060
Jul 2018030
Sep 2018010
Oct 2018010
Dec 2018010
Jan 2021010
Feb 2021010
Mar 2021010
Apr 2021010
May 2021010
Jun 2021010
Jul 2021010
Aug 2021010
Sep 2021010
Oct 2021010
Nov 2021010
Dec 2021010
Jan 2022010
Feb 2022010
Mar 2022010
Apr 2022010
May 2022010
Jun 2022010
Jul 2022010
Aug 2022010
Sep 2022010
Oct 2022010
Nov 2022010
Dec 2022010
Jan 2023010
Feb 2023010
Mar 2023010
Apr 2023010

PreviousNext
Back to top

In this issue

Journal of Pharmacology and Experimental Therapeutics: 302 (3)
Journal of Pharmacology and Experimental Therapeutics
Vol. 302, Issue 3
1 Sep 2002
  • Table of Contents
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Correction to “Presynaptic Muscarinic M2-Receptor-Mediated Inhibition of N-Type Ca2+Channels in Cultured Sphenopalatine Ganglion: Direct Evidence for Acetylcholine Inhibition of Cerebral Nitrergic Neurogenic Vasodilation”
(Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
(Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
CorrectionErratum

Correction to “Presynaptic Muscarinic M2-Receptor-Mediated Inhibition of N-Type Ca2+Channels in Cultured Sphenopalatine Ganglion: Direct Evidence for Acetylcholine Inhibition of Cerebral Nitrergic Neurogenic Vasodilation”

Journal of Pharmacology and Experimental Therapeutics September 1, 2002, 302 (3) 1303;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
CorrectionErratum

Correction to “Presynaptic Muscarinic M2-Receptor-Mediated Inhibition of N-Type Ca2+Channels in Cultured Sphenopalatine Ganglion: Direct Evidence for Acetylcholine Inhibition of Cerebral Nitrergic Neurogenic Vasodilation”

Journal of Pharmacology and Experimental Therapeutics September 1, 2002, 302 (3) 1303;
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Correction to “Cannabinoid Tolerance in S426A/S430A x β-Arrestin 2 Knockout Double-Mutant Mice”
  • Correction to “Protein Kinase A–Mediated Effects of Protein Kinase C Partial Agonist 5-(Hydroxymethyl)Isophthalate 1a3 in Colorectal Cancer Cells”
  • Correction to “Rescue of Synaptic Phenotypes and Spatial Memory in Young Fragile X Mice”
Show more Erratum

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics